Q87S19 AF NFT

Dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaiu7lf5q5aeldgrj5afaef6zmuespimtgftvo6dtttmelznugati/metadata.json
IPFS of structure file: 
bafybeic6dh6psiekgwgx3yuhoiu6qhcv6qkzyeajxjodpnsomzvlsrk5pq/AF-Q87S19-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9E72a6c28d20b2443a44F1c57457a027ddE4fa17
First NFT owner address (bech32): 
genesis1nee2ds5dyzeygwjy78zhg4aqylw7f7sh87h2qv
Current NFT ID #378653 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378653
Accession (UniProt):
Q87S19
Name::
Dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
VIBRIO PARAHAEMOLYTICUS SEROTYPE O3:K6 (STRAIN RIMD 2210633)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q87S19 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q87S19|RLMN_VIBPA Dual-specificity RNA methyltransferase RlmN OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=rlmN PE=3 SV=1 MTTEKINLLDFDRKGMRQFFAEELGEKAFRADQVMKWIYHFGVDDFDNMTNINKKLREKLQHKCEIKAPTVAEAQHSSDGTIKWAMKVGDQDVETVYIPEEDRATLCVSSQVGCALECKFCSTAQQGFNRNLKVSEIIGQVWRAAREIGLQKETGRRPITNVVMMGMGEPLLNMKNLIPALEIMLDDLGFGLSKRRVTVSTSGVVSGLDQMTGKIDVALAISLHAPNDKLRSEIMPINDRWDIQDFLASVRRYIASSNANRGKVTVEYVLLDHVNDDMGHARELAELMKDTPCKINLIPFNPYPGSPYKKPSNSRIDRFQKTLMQYEHTVTVRKTRGDDIDAACGQLVGDVIDRTKRTAALKAARGAETIDVKAV